Krka, d. d.
KRK
Rangering i aksjer
#2156
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Aksjekurs
$313.05
Sist synkronisert: 2026-10-19
Markedsverdi
$9.48B
Endring (1 dag)
-1.77%
Endring (1 år)
30.64%
Land
SI
Handel Krka, d. d. (KRK)
Kategori
Healthcare
Utbyttehistorikk for Krka, d. d. (KRK)
Krka, d. d. (aksjesymbol: KRK) har gitt totalt 15 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $250.64
Utbytteavkastning (TTM): 0.0351
Summen av alle utbytter (justert for aksjesplitt): $250.64
Utbytteavkastning (TTM): 0.0351
Utbyttebetalinger for Krka, d. d. (KRK) fra 2012 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $35.17 | 0.00% |
| 2025 | $35.17 | 9.65% |
| 2024 | $32.07 | 13.64% |
| 2023 | $28.22 | 17.23% |
| 2022 | $24.07 | 12.60% |
| 2021 | $21.38 | 17.65% |
| 2020 | $18.17 | 32.81% |
| 2019 | $13.68 | 10.34% |
| 2018 | $12.40 | 5.45% |
| 2017 | $11.76 | 3.77% |
| 2016 | $11.33 | -43.62% |
| 2015 | $20.10 | 123.81% |
| 2014 | $8.98 | 30.44% |
| 2013 | $6.88 | 7.33% |
| 2012 | $6.41 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $35.17 | 0.00% |
| 2025 | $35.17 | 9.65% |
| 2024 | $32.07 | 13.64% |
| 2023 | $28.22 | 17.23% |
| 2022 | $24.07 | 12.60% |
| 2021 | $21.38 | 17.65% |
| 2020 | $18.17 | 32.81% |
| 2019 | $13.68 | 10.34% |
| 2018 | $12.40 | 5.45% |
| 2017 | $11.76 | 3.77% |
| 2016 | $11.33 | -43.62% |
| 2015 | $20.10 | 123.81% |
| 2014 | $8.98 | 30.44% |
| 2013 | $6.88 | 7.33% |
| 2012 | $6.41 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
